Therapeutic Modulation of the MoCo Biosynthesis Pathway to Protect Neurons and Axons from Inflammation-Induced Injury

Technology #2014-299

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Categories
Researchers
Charles L. Howe Ph.D.
Managed By
Leif R. Nelson
Patent Protection
US Patent Pending
US Patent Pending

Mayo Clinic has developed an innovative therapeutic strategy to use molybdenum cofactor (MoCo) to treat neurological inflammatory disease.